Ochratoxin A was given by gavage to male rats. Moribund and dead animals were necropsied, and the surviving rats, including the controls, were killed 48 hours after dosing. Many of the principal rats were moribund, or began dying, within 12 to 24 hours after dosing. Lesions suggestive of disseminated intravascular coagulation were seen by light microscopy as early as 12 hours after dosing; fibrin deposits were in the spleen, brain choroid plexus, glomerular capillaries, liver, and heart. Renal tubular nephrosis, hepatic and lymphoid necrosis, and necrotic enteritis with villous atrophy were also seen. Electron microscopy demonstrated fibrin strands mixed with degranulated platelets, necrotic leukocytes, and swollen endothelial cells in glomerular capillaries. Myocardial changes included focal supercontracted sarcomeres adjacent to intercalated disks. Swollen sarcolemma, lysed myofibrils and fragmented Z-bands with interstitial edema, vascular thrombosis, and endothelial damage were also seen. The acute pathologic changes induced by ochratoxin A in the intestine, liver, and lymphoid tissues were more obvious than the tubular nephrosis, and the development of a disseminated intravascular coagulation-like syndrome with myocardial changes was a complicating factor.
Ochratoxin A (OA), a naturally occurring mycotoxin, is produced by several species of Aspergillus and Penicillium. 27 These fungi are distributed extensively in the natural environment, and much attention has been focused on OA as an environmental hazard to farm animals and humans. 21 Ochratoxin A has been suggested as a causative agent of endemic nephropathy in farm animals and humans. 27 Pathologic changes experimentally induced by OA have been described in the rat,15,22,23 pig,25 dog,18 duckling, 26 and chicken. 6 Changes included renal tubular necrosis, hepatic and lymphoid necrosis, and intestinal ulceration. Rats given high doses of OA showed multiple hemorrhagic foci in several organs during the final stages of ochratoxicosis.7 A study on hemostasis showed a drop in plasma fibrinogen and decreases in factors 11, VII, and X, and in the thrombocyte and megakaryocyte counts in rats intoxicated with OA. 7 Myocardial lesions have also been reported in experimental OA toxicity in rats. 23 The objectives of this study were: (1) to characterize and describe lesions produced by OA in rats, with special emphasis on myocardial and intestinal lesions; and (2) to investigate the possibility of disseminated intravascular coagulation development in rats exposed to OA at the light and electron microscopic levels.
Materials and Methods
Thirty each of male Long-Evans and Sprague-Dawley rats were obtained from a commercial source (Charles River Canada, St. Constant, Quebec). Upon amval, they were placed in individual stainless steel mesh-bottomed cages and were housed in an environmentally controlled room (20 k 2 C, relative humidity 50 f 20%, 12 hr light, 12 hr dark) and provided a commercial ration (Purina Certified Rodent Chow, St. Louis, MO) and reverse osmosis water ad libitum.
Benzene-free ochratoxin A (Sigma, St. Louis, MO), dissolved in 0.1 M sodium bicarbonate, was administered in single oral doses of 0, 17, and 22 mg/kg to groups of 10 rats of each strain. The solvent dose was 10 mVkg for treated and control groups. Moribund rats were killed and necropsied immediately. Dead rats were necropsied within 2 hours after death. Surviving rats were killed 48 hours after dosing. Body weights were recorded at the time of dosing and at necropsy.
For light microscopy, tissues were fixed in 10% neutral buffered formalin. Tissue blocks were processed by routine techniques, sectioned at 5 pm, and stained with hematoxylin and eosin (HE). Additional sections from liver, spleen, heart, kidney, and brain were stained by phosphotungstic acid-hematoxylin (PTAH).
For electron microscopy, samples (0.5-1.0 mm3 in size) of renal cortex and left and right ventricles of heart were collected prior to formalin fixation from euthanatized animals, fixed in Karnovsky's fixative,16 washed in cacodylate buffer, post-fixed in 1% osmium tetroxide, dehydrated in graded alcohols and propylene oxide, and flat embedded in epoxy resin. Blocks from 25 animals (1 1 at high dose, ten at low dose and four control) were examined. A minimum of four blocks and two sections from each block were examined from each tissue sample. The electron microscopic evaluation was conducted in a "blind" fashion, that is, without knowledge of the treatment of the animals.
Morphometric analysis was done on formalin-fixed histologic jejunal sections using a light microscope with drawing attachment (Camera Lucida), stylus, digitizer tablet, and a represented the distance between the tip of the villus and a point in the middle of the villus base at the crypt shoulder level. The crypt length (C) represented the distance between the latter point (crypt shoulder level) and the crypt basement membrane facing the muscularis mucosae. The data on crypt and villous lengths and C/V ratio were evaluated by a twoway analysis of variance model to study the effects of dose (control, low, high dose) and time of kill (0-24,48 hr) within the strain (Long-Evans, Sprague-Dawley). Significant differences among means of dose, time, and their interactions were determined by applying the least significant difference test.
Results
The principal rats of both strains had similar clinical signs and pathologic changes. Many of these were moribund 12 hours after dosing and six rats from both strains died 20-22 hours after dosing. The remainder were recovering 24 hours after dosing. The dose-related effects on the time of death or euthanasia and loss of body weight are given in Table 1 . More rats receiving the low dose survived the trial period of 48 hours than rats receiving the high dose. At 12-24 hours after dosing, the small intestine, particularly the jejunum, was dilated with yellowish watery content mixed with mucus and fibrin clots. Multiple focal hemorrhages of various sizes were in the urinary bladder, stomach, intestine, subendocardial region of heart, spleen, and liver. The adrenals were congested and swollen. No clinical signs were seen in animals prior to necropsy at 48 hours after dosing. Animals killed 48 hours after dosing had pale livers and kidneys, and grey-red bone marrow.
Microscopic alterations were seen in the kidneys, heart, liver, thymus, lymph nodes, spleen, bone marrow, adrenals, intestine, colon, and brain choroid plexus. Renal lesions were in proximal convoluted tubules and glomeruli. The earliest tubular changes were seen in animals killed 12 hours after dosing and were characterized by swelling of epithelial cells, many of which contained eosinophilic hyaline droplets. At 20-24 hours, the tubular lesions had progressed to marked swelling of epithelial cells with many hyaline droplets.
Only a few cells had condensed nuclei, and tubular lumens contained finely granular eosinophilic proteinaceous casts. Animals killed 48 hours after dosing had mildly swollen epithelial cells in the proximal con- Table 2 . Incidence of organ involvement by fibrin thrombi in principal rats after oral ochratoxin A (OA) administration. mens were completely filled with necrotic debris, platelets, and fibrin deposits. Most of the platelets were degranulated (Fig. 2) . Electron-dense, closely packed, finely granular, and fibrillar material that did not demonstrate the characteristic striated strands of fibrin were seen in some capillary loops mixed with platelets and necrotic debris. By 48 hours, most of the examined capillaries were open, although some loops contained small fibrin strands admixed with cellular debris. The endothelial lining was swollen, and more necrotic leukocytes were seen in glomerular capillaries. Most of the necrotic cells had lymphocyte-type morphology, with round, electron-dense, homogeneous dark nuclei surrounded by a thin rim of cytoplasm. No fibrin strands were seen between the mesangial cells or in the tubules.
The myocardial changes during the first 24 hours after dosing included intercellular edema and hypercontraction bands of the muscle fibers ( Fig. 3) . These changes were focal in distribution and associated with penvascular edema. Partial or complete occlusion of a few venules with fibrin thrombi were also seen. At 48 hours, the edema was less obvious, and many small blood vessels contained necrotic leukocytes. Two rats necropsied at 48 hours had large focal areas of necrosis in the left atrium and ventricle, respectively. The affected fibers appeared fragmented, hypereosinophilic, and without evidence of striation (Fig. 4) . The nuclei were pyknotic, and calcium deposition was present in a few fibers. Mild edema and hemorrhage were seen between the necrotic fibers. At the ultrastructural level, vascular and parenchymal lesions were evident 12-24 hours after dosing. The vascular changes were characterized by swelling and blebbing of the endothelial lining of some small arterioles and venules. Only individual arterioles and venules were affected in the same section. Severe damage to the endothelial lining with platelet adhesion to the basement membrane was seen; the lumens were partially or completely filled with fibrin strands, platelets, and necrotic white blood cells (Figs. 5, 6 ). Many of the capillaries were totally occluded by necrotic cellular debris. The parenchymal lesions consisted of focal hypercontracted areas within myocytes, involved several sarcomeres, and were usually located adjacent to intercalated disks. The involved cells had severe swelling and blebbing of the sarcolemma, lysed myofibrils, and fragmented Z-bands. Changes in the mitochondria varied from mild to moderate swelling. There was severe depletion of glycogen granules between the affected myofibrils. Perivascular and intercellular edema were seen in the affected areas as well (Fig. 7) . By 48 hours, the lesions were limited to individual fibers and characterized by extensive lysis of sarcomeres with swelling of mitochondria and formation of matrical-dense granules (Fig. 8 ). The nuclei of affected fibers had clumped and marginated nuclear chromatin along or adjacent to the nuclear envelope. No endothelial changes were seen in the examined blood vessels; however, the lumens contained many necrotic white blood cells.
Two types of lesions were seen in the livers of animals which died or were killed during the first 24 hours after dosing. One was seen in all principal rats and characterized by multifocal, randomly distributed areas of hepatic necrosis. The size of the necrotic areas varied from single cell necrosis to large areas of 100-1 50 pm in diameter. In many rats, the necrotic areas were infiltrated with neutrophils and macrophages. Most neutrophils appeared necrotic. Perivascular hepatocellular necrosis was commonly seen in the affected animals. The lesions were more pronounced around portal and central veins. Some of these blood vessels contained fibrin thrombi. The bile duct epithelium appeared disorganized with no identifiable lumina. The other lesion was less frequent, was seen in conjunction with the type one lesions, and resembled areas of hepatic infarction. They appeared as large areas of hemorrhagic coagulation necrosis with no inflammatory reaction. Vascular thrombosis was seen in a few instances, mostly associated with hepatic necrosis. At 48 hours, the hepatic changes consisted of single cell necrosis around blood vessels, increased mitotic figures of hepatocytes, and early organization of thrombi.
The splenic changes during the first 24-hour period included hemorrhage and cellular necrosis of the red pulp. The necrosis involved neutrophils, lymphocytes, and reticular cells. Large numbers of necrotic lymphocytes were seen in the white pulp. The necrosis involved the cortical and medullary regions of the lymphoid follicles. At 48 hours, the spleen was smaller, due to cellular necrosis and absence of vascular congestion. The red and white pulps had multiple focal areas of necrotic cells. These necrotic cells appeared to be located inside macrophages. Lymphocytic depletion of the germinal centers and presence of immature lymphocytes were seen in the lymphoid follicles of the white pulp. The lymphoid changes in the lymph nodes, thymus, and Peyer's patches were similar to those seen in the splenic lymphoid follicles.
No pathological changes were seen in the brain; however, thrombosis of the choroid plexus small blood vessels was frequently seen in the principal animals at both time periods ( Table 2) .
The adrenal gland had the primary alteration of necrosis confined to individual cells of the zona fasiculata region. This lesion was frequently seen in animals killed during the first 24 hours after dosing. The necrotic cells were also associated with mild vascular congestion and hemorrhage.
The severity of the intestinal lesions was dose-and time-dependent. They were found only in animals killed in extremis during the first 24 hours post-exposure to ochratoxin A (OA). During this time period, there were more animals examined from the high dose group than from the low dose group. The earliest villous changes included vacuolation of absorptive epithelial cells at the tip of the villi. The lamina propria at the tip of the villi appeared necrotic, and blood vessels were dilated with erythrocytes and necrotic leukocytes. A few sloughed epithelial cells were also seen in the lumen. These changes progressed to more extensive necrosis of the lamina propria. The smooth muscle fibers ex- Fig. 8 . Myocardial fiber near intercalated disk with advanced lysis of fibrils, disintegration of Z-bands, and mild swelling of mitochondria. Hypercontraction bands with mild swelling of mitochondria on the other side of the disk, 48 hours after dosing. Bar = 2 Mm. Fig. 9 . Advanced stage of intestinal villous damage; villi are markedly shortened and fused, rat killed 20 hours after dosing. HE. Bar = 100 pm. indicated a significant dose and time response to OA toxicity in both strains ( Table 3) . Except for Sprague-Dawley rats receiving the low dose, all principal animals killed during the first 24 hours post-inoculation had significantly higher C/V ratio than the controls. Principal animals killed 48 hours after dosing did not have any difference in C/V ratio when compared to controls. The high C/V ratio of the principal rats was due to significant reduction in villous length with no change in crypt length. A dose response was noted when the data were analyzed without considering the time of death. Only high dose exposure produced a significantly higher C/V ratio as compared to the controls.
Thrombi were seen most frequently in the spleen, followed by brain, liver, kidney, and heart ( Table 2) .
More Long-Evans rats with fibrin thrombi were noticed compared to Sprague-Dawley rats; however, the distribution was similar. During the first 24 hours, higher percentages of fibrin thrombi were seen and the incidence declined in principal animals killed 48 hours after dosing. No significant lesions were detected by light or electron microscopy in tissues from control rats.
Discussion
In this study, moribund animals had multifocal hemorrhages in several organs and disseminated fibrin deposition in capillaries as early as 12 hours after dosing. These lesions appeared similar to those described in humans and animals which have died with disseminated intravascular coagulation (DIC). 1 1~1 7 . 2 8 One sug- gests that the multiple hemorrhages seen in ochratoxin A (OA) rats are most likely due to consumption coagulopathy. The DIC-like lesions in this study were probably due to activation of the extrinsic and intrinsic systems of coagulation. Activation of the extrinsic system occurs with tissue necrosis which releases procoagulant (thromboplastic) material. Intrinsic system activation occurs with endothelial damage and the release of Hageman factor. Platelets and leukocytes release phospholipids which activate the intrinsic and extrinsic ~y s t e m s .~,~~ In this study, vascular endothelial damage, leukocyte necrosis, platelet degranulation, and extensive tissue necrosis were seen in multiple organs. These results are in agreement with Galtier's s t~d y ,~ which suggested that DIC is a complicating factor to OA toxicity in rats. Previous reports7J5.22,23 did not describe fibrin deposits in the kidney of OA-inoculated rats. This might be attributed to the time at which the animals were killed or to postmortem fibrinolysis. Ochratoxin A is a derivative of dihydroisocoumarin, which is linked to L-P-phenylalanine by an amide bond through its 7 cargoxyl group2' It has been suggested that OA may produce anticoagulant effects similar to those induced by coumarin by antagonizing vitamin K7 The anticoagulant effects of OA, which can cause a hemorrhagic diathesis, were not evident in this study. Coumarins interfere with the synthesis of prothrombin in the liver and their effects as anticoagulants may not be seen for 48 hours after dosing;2 that is, until plasma prothrombin levels have fallen sufficiently to reduce clotting efficiency. This would suggest that the anticoagulant effect of OA does not appear until 48 hours after dosing. This suggestion is in agreement with previous where decreases in Factors 11, VII, and X have been reported in rats 4 to 10 days after dosing with ochratoxin A. Similar aberrations in the coagulation of blood were reported in chickens 3 weeks after dietary feeding of OA, aflatoxin, or T2 toxin6 In ad-dition, chronic aflatoxicosis in dogs has been associated with terminal hemorrhagic diathesis attributed to hepatic damage and DIC.lo Recent report^^.^ of aflatoxicosis in rabbits have indicated that the coagulation defect is due to decreased hepatic protein synthesis, including coagulation factors, except when acute, severe, hepatic necrosis is sufficient to initiate intravascular coagulation with secondary decrease in activity of coagulation factors. In this study, a primary or secondary decrease in the coagulation factors is not known, and the evidence for DIC is microscopic only. Further studies are needed to explore the mechanisms of coagulation defects associated with ochratoxicosis by exposing animals to lower OA doses for several days.
Myocardial changes in zonal necrosis of fibers with hypercontraction bands and intercellular and intracellular edema have been reported in humans and dogs with hemorrhagic ~h o~k .~,~~'~.~~ Animals with hemorrhagic shock usually have focal myocardial lesions occurring adjacent to the intercalated disc, but only a portion of the myocyte is affected. It has been reported that these zonal lesions are reversible, and, therefore, only a few lesions remain 48 hours post-shock induction. In the present study, zonal lesions were seen in the myocardium of rats primarily 12-24 hours after OA dosing. The large areas of necrosis seen in two animals 48 hours after dosing were consistent with ischemic lesions due to vascular thrombosis. These myocardial changes at both time periods suggest that OA is not a cardiotoxic agent, and the cardiac lesions are probably related to shock and subsequent ischemic injuries.
Enteritis with marked villous atrophy was seen in this study 12-24 hours after dosing. Villous atrophy has not been reported in acute OA toxicity in rats, although necrotic enteritis has been described in rats intoxicated with OA.I5 Necrosis of the lamina propria was the earliest lesion detected in the present study.
Subsequent changes included villous epithelial necrosis, and desquamation and terminal collapse of the villi. Similar morphological changes have been reported in rats and mice following propionitrile injection, X-irradiation, reserpin treatment, and application of local hyperthermia to the intestinal ~a l l .~J~-'~ A previous studys has demonstrated that rats administered OA with sulfamethoxypyridazine had a doserelated decrease in the toxicity of the myoctoxin. These findings suggest that the severe enteric lesions associated with ochratoxicosis in rats contribute significantly to the lethal toxicity of OA, and the gut flora may play a role in the pathogenesis of OA enteritis.
